Tildrakizumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14004 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 47 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | severe nonproliferative diabetic retinopathy | KG + DL |
| 2 | diabetic retinopathy | KG + DL |
| 3 | diabetic cataract | KG + DL |
| 4 | drug-induced osteoporosis | KG + DL |
| 5 | nuclear senile cataract | KG + DL |
| 6 | cortical cataract | KG + DL |
| 7 | senile cataract | KG + DL |
| 8 | mature cataract | KG + DL |
| 9 | craniostenosis cataract | KG + DL |
| 10 | immature cataract | KG + DL |
| 11 | diabetes mellitus type 2 associated cataract | KG + DL |
| 12 | tetanic cataract | KG + DL |
| 13 | dermatitis | KG + DL |
| 14 | neonatal dermatomyositis | KG + DL |
| 15 | amyopathic dermatomyositis | KG + DL |
| 16 | acrodermatitis chronica atrophicans | KG + DL |
| 17 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 18 | acne keloid | KG + DL |
| 19 | hydroa vacciniforme, familial | KG + DL |
| 20 | acne (disease) | KG + DL |
| 21 | psoriasis | KG + DL |
| 22 | primary release disorder of platelets | KG + DL |
| 23 | pseudo-von Willebrand disease | KG + DL |
| 24 | Glanzmann thrombasthenia | KG + DL |
| 25 | pityriasis lichenoides | KG + DL |
| 26 | cholestasis | KG + DL |
| 27 | benign recurrent intrahepatic cholestasis | KG + DL |
| 28 | hemorrhagic disease of newborn | KG + DL |
| 29 | zinc, elevated plasma | KG + DL |
| 30 | non-syndromic visceral malformation | KG + DL |
| 31 | biliary atresia intrahepatic | KG + DL |
| 32 | familial intrahepatic cholestasis | KG + DL |
| 33 | HER2 positive breast carcinoma | KG + DL |
| 34 | nevus of Ito | KG + DL |
| 35 | Mirizzi syndrome | KG + DL |
| 36 | microvillus inclusion disease | KG + DL |
| 37 | mitochondrial DNA depletion syndrome, hepatocerebral form | KG + DL |
| 38 | inborn disorder of bilirubin metabolism | KG + DL |
| 39 | bilirubin metabolism disease | KG + DL |
| 40 | progesterone-receptor positive breast cancer | KG + DL |
| 41 | normal breast-like subtype of breast carcinoma | KG + DL |
| 42 | breast tumor luminal A or B | KG + DL |
| 43 | parapsoriasis | KG + DL |
| 44 | progesterone-receptor negative breast cancer | KG + DL |
| 45 | adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency | KG + DL |
| 46 | hereditary North American Indian childhood cirrhosis | KG + DL |
| 47 | chromosome 17q12 deletion syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.